Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-122579
Filing Date
2014-03-31
Accepted
2014-03-31 06:48:39
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d678994d10k.htm 10-K 1496434
2 EX-31.1 d678994dex311.htm EX-31.1 7777
3 EX-31.2 d678994dex312.htm EX-31.2 7756
4 EX-32.1 d678994dex321.htm EX-32.1 4186
5 EX-32.2 d678994dex322.htm EX-32.2 4146
7 GRAPHIC g678994g02j21.jpg GRAPHIC 33080
8 GRAPHIC g678994g22q59.jpg GRAPHIC 19308
9 GRAPHIC g678994g23z17.jpg GRAPHIC 68227
10 GRAPHIC g678994g33w47.jpg GRAPHIC 23231
11 GRAPHIC g678994g45v80.jpg GRAPHIC 41415
12 GRAPHIC g678994g61d07.jpg GRAPHIC 57019
13 GRAPHIC g678994g61g91.jpg GRAPHIC 18217
  Complete submission text file 0001193125-14-122579.txt   1881354
Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36310 | Film No.: 14727784
SIC: 2834 Pharmaceutical Preparations